Obstacles and opportunities for the future of genomic medicine

Molecular Genetics and Genomic Medicine

Volumn 2, Issue 3, 2014, Pages 205-

  Solomon, Benjamin D ^a  

^a BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84924725169     PISSN: None     EISSN: 23249269     Source Type: Journal    
DOI: 10.1002/mgg3.78     Document Type: Note

References (27)

1. Ashley, E. A., A. J. Butte, M. T. Wheeler, R. Chen, T. E. Klein, F. E. Dewey, et al. 2010. Clinical assessment incorporating a personal genome. Lancet 375:1525–1535.
2. Boycott, K. M., M. R. Vanstone, D. E. Bulman, and A. E. MacKenzie. 2013. Rare-disease genetics in the era of next-generation sequencing: discovery to translation. Nat. Rev. Genet. 14:681–691.
3. Consortium, E. P., B. E. Bernstein, E. Birney, I. Dunham, E. D. Green, C. Gunter, et al. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489:57–74.
4. Dewey, F. E., M. E. Grove, C. Pan, B. A. Goldstein, J. A. Bernstein, H. Chaib, et al. 2014. Clinical interpretation and implications of whole-genome sequencing. JAMA 311:1035– 1045.
5. Emond, M. J., T. Louie, J. Emerson, W. Zhao, R. A. Mathias, M. R. Knowles, et al. 2012. Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis. Nat. Genet. 44:886–889.
6. Feero, W. G. 2014. Clinical application of whole-genome sequencing: proceed with care. JAMA 311:1017–1019.
7. Francke, U. 2013. How will genomic information become integrated into the health care system? Mol. Genet. Genomic Med. 1:67–70.
8. Gonsalves, S. G., D. Ng, J. J. Johnston, J. K. Teer, P. D. Stenson, D. N. Cooper, et al. 2013. Using exome data to identify malignant hyperthermia susceptibility mutations. Anesthesiology 119:1043–1053.
9. Hayden, E. C. 2014. Technology: the $1,000 genome. Nature 507:294–295.
10. Hennekam, R. C., and L. G. Biesecker. 2012. Next-generation sequencing demands next-generation phenotyping. Hum. Mutat. 33:884–886.
11. Johnston, J. J., W. S. Rubinstein, F. M. Facio, D. Ng, L. N. Singh, J. K. Teer, et al. 2012. Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes. Am. J. Hum. Genet. 91:97–108.
12. Korf, B. R. 2013. Genomic medicine: educational challenges. Mol. Genet. Genomic Med. 1:119–122.
13. Lander, E. S., L. M. Linton, B. Birren, C. Nusbaum, M. C. Zody, J. Baldwin, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409:860–921.
14. Lupski, J. R., J. G. Reid, C. Gonzaga-Jauregui, D. Rio Deiros, D. C. Chen, L. Nazareth, et al. 2010. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N. Engl. J. Med. 362:1181–1191.
15. Manolio, T. A., R. L. Chisholm, B. Ozenberger, D. M. Roden, M. S. Williams, R. Wilson, et al. 2013. Implementing genomic medicine in the clinic: the future is here. Genet. Med. 15:258–267.
16. Mardis, E. R. 2010. The $1,000 genome, the $100,000 analysis? Genome Med. 2:84.
17. Niu, D. K., and L. Jiang. 2013. Can ENCODE tell us how much junk DNA we carry in our genome? Biochem. Biophys. Res. Commun. 430:1340–1343.
18. Piton, A., C. Redin, and J. L. Mandel. 2013. XLID-causing mutations and associated genes challenged in light of data from large-scale human exome sequencing. Am. J. Hum. Genet. 93:368–383.
19. Rommens, J. M., M. C. Iannuzzi, B. Kerem, M. L. Drumm, G. Melmer, M. Dean, et al. 1989. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245:1059–1065.
20. Solomon, B. D. 2014a. Incidentalomas in genomics and radiology. N. Engl. J. Med. 370:988–990.
21. Solomon, B. D. 2014b. Enhancing the incidental pipeline in genomic sequencing. Mol. Syndromol. 5:4.
22. Solomon, B. D., D. W. Hadley, D. E. Pineda-Alvarez, N. C. S. Program, A. Kamat, J. K. Teer, et al. 2012. Incidental medical information in whole-exome sequencing. Pediatrics 129:e1605–e1611.
23. Solomon, B. D., A. D. Nguyen, K. A. Bear, and T. G. Wolfsberg. 2013. Clinical genomic database. Proc. Natl. Acad. Sci. USA 110:9851–9855.
24. Sosnay, P. R., K. R. Siklosi, F. Van Goor, K. Kaniecki, H. Yu, N. Sharma, et al. 2013. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat. Genet. 45:1160–1167.
25. Tarczy-Hornoch, P., L. Amendola, S. J. Aronson, L. Garraway, S. Gray, R. W. Grundmeier, et al. 2013. A survey of informatics approaches to whole-exome and whole-genome clinical reporting in the electronic health record. Genet. Med. 15:824–832.
26. Xue, Y., Y. Chen, Q. Ayub, N. Huang, E. V. Ball, M. Mort, et al. 2012. Deleterious-and disease-allele prevalence in healthy individuals: insights from current predictions, mutation databases, and population-scale resequencing. Am. J. Hum. Genet. 91:1022–1032.
27. Yang, Y., D. M. Muzny, J. G. Reid, M. N. Bainbridge, A. Willis, P. A. Ward, et al. 2013. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N. Engl. J. Med. 369:1502–1511.